J. Gregory Cairncross

Researcher Next ID · RN-004292

Researcher · Medicine

Calgary, Canada

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Glioma Diagnosis and Treatment

Brain Metastases and Treatment

Meningioma and schwannoma management

Cancer, Hypoxia, and Metabolism

Epigenetics and DNA Methylation

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70025-7
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043330
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043331
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas
JNCI Journal of the National Cancer Institute · 1998 · https://doi.org/10.1093/jnci/90.19.1473
Response criteria for phase II studies of supratentorial malignant glioma.
Journal of Clinical Oncology · 1990 · https://doi.org/10.1200/jco.1990.8.7.1277

No projects listed.